Investigational simufilam failed to reduce cognitive or functional decline in Alzheimer's disease patients in the ReThink-ALZ ...

Alzheimer’s is the most common type of dementia. Music therapy can improve mood and cognitive performance in Alzheimer’s ...

The International Working Group discussed diagnosing Alzheimer's disease among cognitively unimpaired individuals in a ...

Cassava Sciences' simufilam failed a Phase III trial for Alzheimer's disease, likely marking the end of a drug surrounded by ...

Using genetic tools, the scientists then blocked TYK2 in the mice with Alzheimer's. This resulted in a reduction in the ...

Tau behaves abnormally in the brain in people with Alzheimer’s disease. This latest study points to a reason why.

Guided by the Alzheimer's Disease Prevention and Preparedness Task Force, California has taken “significant” action and made ...

Italian researchers have developed a nasal spray showing promise in slowing Alzheimer's progression. Tests on mice with ...

"Alector stock drops after Alzheimer’s drug fails in Phase II trial" was originally created and published by Clinical Trials ...

Subtle signs of Alzheimer's disease can emerge decades before a diagnosis—often in the form of irregular behaviors that ...

I want to express my gratitude to Sen. Bob Casey for his steadfast dedication to the fight against Alzheimer’s disease during ...

APOE4 carriers had higher blood-brain barrier permeability, even without cognitive decline or amyloid beta buildup, ...